Cargando…

Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy

PURPOSE: This study analyzes clinical consequences and dosimetric variations after imperfect brachytherapy insertions. It examines treatment decisions after such insertions in patients having difficult anatomy, which leads to good subsequent insertions with acceptable dose volume parameters. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakrabarti, Bikramjit, Pal, Suparna Kanti, Sepai, Harris Mahammad, Roy, Somapriya Basu, Kar, Sanjay Kr., Lahiri, Annesha, Das, Sounik, Bala, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142650/
https://www.ncbi.nlm.nih.gov/pubmed/30237816
http://dx.doi.org/10.5114/jcb.2018.77954
_version_ 1783355865814794240
author Chakrabarti, Bikramjit
Pal, Suparna Kanti
Sepai, Harris Mahammad
Roy, Somapriya Basu
Kar, Sanjay Kr.
Lahiri, Annesha
Das, Sounik
Bala, Amit
author_facet Chakrabarti, Bikramjit
Pal, Suparna Kanti
Sepai, Harris Mahammad
Roy, Somapriya Basu
Kar, Sanjay Kr.
Lahiri, Annesha
Das, Sounik
Bala, Amit
author_sort Chakrabarti, Bikramjit
collection PubMed
description PURPOSE: This study analyzes clinical consequences and dosimetric variations after imperfect brachytherapy insertions. It examines treatment decisions after such insertions in patients having difficult anatomy, which leads to good subsequent insertions with acceptable dose volume parameters. MATERIAL AND METHODS: We reviewed images of all insertions performed during last one year and sorted faulty ones out. Clinical outcome was assessed, analyzing original treatment records. Repeat three-dimensional planning using identical dose-optimization-technique compared their dosimetry. Statistical analysis using SPSS(®)-Statistics-software included Fisher’s-exact-test to analyze predisposing factors for faulty insertions and predictive factors for subsequent satisfactory insertion. Friedman test was used to compare dose-volume-effects of normalization. RESULTS: Eighteen of 292 brachytherapy plans revealed imperfect insertions, including thirteen perforations (4.5%). Lack of pre-planning, obstructing mass, narrow vagina, acute anteversion of uterus, and multi-parity were significant (p ≤ 0.05) predisposing factors for atypical insertions. Satisfactory optimization was possible after correcting acute anteflexion or positioning tandem in retroverted direction in uncorrectable retroverted uterus. Dose normalization at point A shifted optimized dose from contoured volume to point of normalization, often undesirably. This difference, however, was statistically not significant (p = 0.121). In patients having obstructing mass, subsequent insertions were perfect, and dose volume parameters were acceptable only when full prescribed dose was delivered to at least 60% volume of the mass after a faulty insertion (p < 0.001). CONCLUSIONS: Pre-planning by imaging is suggested in all cases of brachytherapy. Insertion of adequate length of tandem aligned to uterine axis is warranted for adequate tumor coverage. Whenever detected, acute anteflexion and mobile retroversion should be corrected. Tandem inserted in retroverted direction in uncorrectable retroverted uterus generates acceptable dose volume parameters. In cases with obstructive cervical mass, good subsequent insertion is possible with acceptable dose volume parameters, if planned dose can be delivered to its 60% volume.
format Online
Article
Text
id pubmed-6142650
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-61426502018-09-20 Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy Chakrabarti, Bikramjit Pal, Suparna Kanti Sepai, Harris Mahammad Roy, Somapriya Basu Kar, Sanjay Kr. Lahiri, Annesha Das, Sounik Bala, Amit J Contemp Brachytherapy Original Paper PURPOSE: This study analyzes clinical consequences and dosimetric variations after imperfect brachytherapy insertions. It examines treatment decisions after such insertions in patients having difficult anatomy, which leads to good subsequent insertions with acceptable dose volume parameters. MATERIAL AND METHODS: We reviewed images of all insertions performed during last one year and sorted faulty ones out. Clinical outcome was assessed, analyzing original treatment records. Repeat three-dimensional planning using identical dose-optimization-technique compared their dosimetry. Statistical analysis using SPSS(®)-Statistics-software included Fisher’s-exact-test to analyze predisposing factors for faulty insertions and predictive factors for subsequent satisfactory insertion. Friedman test was used to compare dose-volume-effects of normalization. RESULTS: Eighteen of 292 brachytherapy plans revealed imperfect insertions, including thirteen perforations (4.5%). Lack of pre-planning, obstructing mass, narrow vagina, acute anteversion of uterus, and multi-parity were significant (p ≤ 0.05) predisposing factors for atypical insertions. Satisfactory optimization was possible after correcting acute anteflexion or positioning tandem in retroverted direction in uncorrectable retroverted uterus. Dose normalization at point A shifted optimized dose from contoured volume to point of normalization, often undesirably. This difference, however, was statistically not significant (p = 0.121). In patients having obstructing mass, subsequent insertions were perfect, and dose volume parameters were acceptable only when full prescribed dose was delivered to at least 60% volume of the mass after a faulty insertion (p < 0.001). CONCLUSIONS: Pre-planning by imaging is suggested in all cases of brachytherapy. Insertion of adequate length of tandem aligned to uterine axis is warranted for adequate tumor coverage. Whenever detected, acute anteflexion and mobile retroversion should be corrected. Tandem inserted in retroverted direction in uncorrectable retroverted uterus generates acceptable dose volume parameters. In cases with obstructive cervical mass, good subsequent insertion is possible with acceptable dose volume parameters, if planned dose can be delivered to its 60% volume. Termedia Publishing House 2018-08-31 2018-08 /pmc/articles/PMC6142650/ /pubmed/30237816 http://dx.doi.org/10.5114/jcb.2018.77954 Text en Copyright: © 2018 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Chakrabarti, Bikramjit
Pal, Suparna Kanti
Sepai, Harris Mahammad
Roy, Somapriya Basu
Kar, Sanjay Kr.
Lahiri, Annesha
Das, Sounik
Bala, Amit
Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy
title Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy
title_full Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy
title_fullStr Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy
title_full_unstemmed Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy
title_short Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy
title_sort clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142650/
https://www.ncbi.nlm.nih.gov/pubmed/30237816
http://dx.doi.org/10.5114/jcb.2018.77954
work_keys_str_mv AT chakrabartibikramjit clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy
AT palsuparnakanti clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy
AT sepaiharrismahammad clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy
AT roysomapriyabasu clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy
AT karsanjaykr clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy
AT lahiriannesha clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy
AT dassounik clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy
AT balaamit clinicalanddosimetricconsequencesofimperfectapplicatorinsertionincervicalcancerbrachytherapy